4//SEC Filing
Schwartzberg Gil 4
Accession 0001493152-20-023083
CIK 0001335105other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 7:39 PM ET
Size
18.7 KB
Accession
0001493152-20-023083
Insider Transaction Report
Form 4
Schwartzberg Gil
10% Owner
Transactions
- Purchase
Common Stock
2020-11-30$4.75/sh+105,264$500,004→ 247,775 total - Purchase
Warrant to Purchase Common Stock
2020-11-30$4.75/sh+105,264$500,004→ 105,264 totalExercise: $5.70From: 2020-11-30Exp: 2025-11-30→ Common (105,264 underlying)
Holdings
- 16,667(indirect: By Trust)
Common Stock
- 16,667(indirect: By Trust)
Common Stock
- 291,667(indirect: By Trust)
Options to Purchase Common Stock
Exercise: $3.00From: 2015-01-28Exp: 2024-01-28→ Common (291,667 underlying) - 83,333(indirect: By Trust)
Warrant to Purchase Common Stock
Exercise: $6.00From: 2018-12-07Exp: 2022-11-30→ Common (83,333 underlying) - 375,926(indirect: By Trust)
Common Stock
- 83,333(indirect: By Trust)
Warrant to Purchase Common Stock
Exercise: $6.00From: 2018-12-07Exp: 2022-11-30→ Common (83,333 underlying) - 83,333
Options to Purchase Common Stock
Exercise: $3.00From: 2015-01-28Exp: 2024-01-28→ Common (83,333 underlying) - 16,667(indirect: By Trust)
Common Stock
- 186,667(indirect: By Trust)
Common Stock
- 191,667(indirect: By Trust)
Common Stock
- 33,333(indirect: By Trust)
Common Stock
- 106,352(indirect: By Continuum Partners, L.P.)
Common Stock
- 16,667(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The reporting person acquired 105,264 Units, each Unit consisting of one share of Common Stock and a five year warrant at an exercise price of $5.70 per share. The purchase price for a Unit was $4.75 per Unit.
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeother
Related Parties
1- filerCIK 0001472409
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 7:39 PM ET
- Size
- 18.7 KB